ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancer

INTRODUCTION: Despite some of the oncogenic driver mutations that have been associated with increased expression of programmed death-ligand 1 (PD-L1), the correlation between PD-L1 expression and ROS1 fusion in NSCLC cells, especially for those with Crizotinib resistance has not been fully addressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zheng, Zhao, Kejia, Wei, Shiyou, Liu, Chengwu, Zhou, Jiankang, Gou, Qiheng, Wu, Xia, Yang, Zhenyu, Yang, Yanbo, Peng, Yong, Cheng, Qing, Liu, Lunxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458663/
https://www.ncbi.nlm.nih.gov/pubmed/32923114
http://dx.doi.org/10.1080/2162402X.2020.1758003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458663/
https://www.ncbi.nlm.nih.gov/pubmed/32923114
http://dx.doi.org/10.1080/2162402X.2020.1758003

Ejemplares similares